|
上海復星醫藥(集團)股份有限公司 - H股, 02196.HK - 綜合損益表 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
2013-12 |
2012-12 |
2011-12 |
2010-12 |
2009-12 |
營業額 |
43,811,385 |
38,864,174 |
30,163,260 |
28,389,277 |
24,713,875 |
18,361,608 |
14,505,584 |
12,502,163 |
11,938,243 |
9,921,487 |
7,278,287 |
6,432,589 |
4,528,773 |
3,850,312 |
經營溢利 |
2,511,481 |
4,006,145 |
3,069,090 |
3,126,854 |
2,180,155 |
2,694,869 |
2,229,868 |
2,253,316 |
1,788,905 |
1,531,147 |
1,313,388 |
1,094,070 |
655,641 |
2,830,644 |
非經營/ 特殊項目 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
聯營公司 |
2,069,071 |
2,036,525 |
1,713,592 |
1,496,013 |
1,399,438 |
1,366,848 |
1,341,681 |
1,118,516 |
929,148 |
782,462 |
809,647 |
633,168 |
546,310 |
436,833 |
除稅前經營溢利 |
4,580,552 |
6,042,670 |
4,677,846 |
4,525,753 |
3,579,593 |
4,061,717 |
3,571,549 |
3,371,832 |
2,718,053 |
2,313,609 |
2,123,035 |
1,727,238 |
1,201,951 |
3,267,477 |
稅項 |
626,918 |
1,066,401 |
737,865 |
782,231 |
559,711 |
476,458 |
350,207 |
501,171 |
348,214 |
358,158 |
283,764 |
341,819 |
201,607 |
700,396 |
少數股東權益 |
216,659 |
247,558 |
277,168 |
421,904 |
311,959 |
460,759 |
415,505 |
410,567 |
256,970 |
372,890 |
275,355 |
219,235 |
136,690 |
66,071 |
股東應占溢利 |
3,736,975 |
4,728,711 |
3,662,813 |
3,321,618 |
2,707,923 |
3,124,500 |
2,805,837 |
2,460,094 |
2,112,869 |
1,582,561 |
1,563,916 |
1,166,184 |
863,654 |
2,501,010 |
貨幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
單位 |
千 |
千 |
千 |
主要項目 |
折舊 |
2,447,605 |
1,948,440 |
1,728,137 |
1,520,479 |
1,317,532 |
919,376 |
718,125 |
637,183 |
542,840 |
407,380 |
283,960 |
207,628 |
153,499 |
135,144 |
利息 |
1,009,571 |
847,015 |
897,497 |
1,094,266 |
937,579 |
588,702 |
491,341 |
475,771 |
424,595 |
365,761 |
380,820 |
318,014 |
166,881 |
135,341 |
利息撥作發展資本 |
45,764 |
24,481 |
16,545 |
19,576 |
7,921 |
11,161 |
3,170 |
5,760 |
9,555 |
15,310 |
10,221 |
4,036 |
4,502 |
2,950 |
處置/重估固定資產 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
稅率(%) |
13.69 |
17.65 |
15.77 |
17.28 |
15.64 |
11.73 |
9.81 |
14.86 |
12.81 |
15.48 |
13.37 |
19.79 |
16.77 |
21.44 |
營業額增長(%) |
12.73 |
28.85 |
6.25 |
14.87 |
34.6 |
26.58 |
16.02 |
4.72 |
20.33 |
36.32 |
13.15 |
42.04 |
17.62 |
|
股東應占溢利增長(%) |
-20.97 |
29.1 |
10.27 |
22.66 |
-13.33 |
11.36 |
14.05 |
16.43 |
33.51 |
1.19 |
34.11 |
35.03 |
-65.47 |
|
核數師意見 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
0 |
0 |
說明:1代表無保留意見;2代表保留意見;3代表修改意見
|
|